XML 15 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 143,078 $ 68,802
Marketable securities, current 256,490 162,073
Accounts receivable 837 80,150
Related party collaboration receivable 2,620 3,341
Prepaid expenses and other current assets 6,112 5,318
Total current assets 409,137 319,684
Property and equipment, net 17,381 16,494
Deposits and other non-current assets 2,890 1,593
Marketable securities, non-current 980  
Operating lease, right-of-use assets 39,204 13,510
Total assets 469,592 351,281
Current liabilities:    
Accounts payable 7,579 1,604
Accrued expenses 7,595 16,823
Other current liabilities 5,940 3,200
Deferred revenue, current 51,439 42,881
Total current liabilities 72,553 64,508
Deferred revenue, non-current 13,157 32,359
Other non-current liabilities 42,996 18,094
Total liabilities 128,706 114,961
Commitments and contingencies (see note 7)
Stockholders' equity:    
Preferred stock, $0.001 par value: 5,000,000 shares authorized at March 31, 2024 and December 31, 2023; no shares issued and outstanding at March 31, 2024 and December 31, 2023
Common stock, $0.001 par value: 120,000,000 shares authorized at March 31, 2024 and December 31, 2023; 54,318,133 and 44,038,333 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively 54 44
Additional paid-in capital 613,850 497,506
Accumulated other comprehensive loss (506) (48)
Accumulated deficit (272,512) (261,182)
Total stockholders' equity 340,886 236,320
Total liabilities and stockholders' equity $ 469,592 $ 351,281